The systemic-onset variant of juvenile idiopathic arthritis needs to be recorded as an autoinflammatory syndrome: Comment on the review by Nigrovic

Arthritis and Rheumatology

Volumn 66, Issue 9, 2014, Pages 2645-

  Rigante, Donato ^a   Cantarini, Luca ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ANTIRHEUMATIC AGENT; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

AUTOINFLAMMATORY DISEASE; CHRONIC INFLAMMATION; CLINICAL FEATURE; GENETIC ASSOCIATION; HUMAN; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ANIMAL; DRUG ANTAGONISM; NOTE;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE; CYTOKINES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN;

EID: 84907412641     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38698     Document Type: Letter

References (5)

1. Nigrovic PA. Is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? [review]. Arthritis Rheumatol 2014;66:1405-13.
2. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2. (Pubitemid 38160763)
3. Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol 2011;7:416-26.
4. Rossi-Semerano L, Kone-Paut I. Is Still's disease an autoinflammatory syndrome? Int J Inflam 2012;2012:480373.
5. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1(IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005;201:1479-86. (Pubitemid 40664091)